A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic Mdx mice

American Journal of Pathology

Volumn 166, Issue 2, 2005, Pages 477-489

  De Luca, Annamaria ^a   Nico, Beatrice ^a   Liantonio, Antonella ^a   Didonna, Maria Paola ^a   Fraysse, Bodvael ^a   Pierno, Sabata ^a   Burdi, Rosa ^a   Mangieri, Domenica ^a   Rolland, Jean François ^a   Camerino, Claudia ^a   Zallone, Alberta ^a   Confalonieri, Paolo ^b   Andreetta, Francesca ^b   Arnoldi, Elisa ^b   Courdier Fruh, Isabelle ^c   Magyar, Josef P ^c   Frigeri, Antonio ^a   Pisoni, Michela ^a   Svelto, Maria ^a   Camerino, Diana Conte ^a  

^a UNIVERSITY OF BARI   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c MyoContract Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CYCLOSPORIN A; FURA 2; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM HOMEOSTASIS; CHLORIDE CONDUCTANCE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; ELECTROPHYSIOLOGY; EXTENSOR DIGITORUM LONGUS MUSCLE; FIBROSIS; FORELIMB; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; TREADMILL EXERCISE; TREATMENT OUTCOME;

EID: 19944430382     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62270-5     Document Type: Article

References (53)

1. Hoffman EP, Dressman D: Molecular pathophysiology and targeted therapeutics for muscular dystrophy. Trends Pharmacol Sci 2001, 22:465-470
2. Alderton JM, Steinhardt RA: How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 2000, 10:268-272
3. Wehling M, Spencer MJ, Tidball JG: A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 2001, 155:123-131
4. 2+-permeable growth factor-regulated channel. J Cell Biol 2003, 161:957-967
5. Chen YW, Zhao P, Borup R, Hoffman EP: Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 2000, 151:1321-1336
6. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W, Andrade FH: A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002, 11:263-272
7. Spencer MJ, Montecino-Rodriguez E, Dorshkind K, Tidball JG: Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol 2001, 98:235-243
8. Dubowitz V, Kinali M, Main M, Mercuri E, Muntoni F: Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol 2002, 6:153-159
9. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Fraysse B, Mirabella M, Servidei S, Ruegg UT, Conte Camerino D: Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther 2003, 304:453-463
10. Kinoshita I, Vilquin JT, Guerette B, Asselin I, Roy R, Tremblay JP: Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994, 17:1407-1415
11. Yuasa K, Sakamoto M, Miyagoe-Suzuki Y, Tanouchi A, Yamamoto H, Li J, Chamberlain JS, Xiao X, Takeda S: Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Ther 2002, 9:1576-1588
12. van Deutekom JC, van Ommen GJ: Advances in Duchenne muscular dystrophy gene therapy. Nat Rev Genet 2003, 4:774-783
13. Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, Croci D, Davies KE, Cornelio F, Pozza O, Karpati G, Gilbert R, Mora M: Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther 2003, 10:750-757
14. Matsuda S, Koyasu S: Mechanisms of action of cyclosporine. Immunopharmacology 2000, 47:119-125
15. Sharma KR, Mynhier MA, Miller RG: Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology 1993, 43:527-532
16. Springer JE, Azbill RD, Nottingham SA, Kennedy SE: Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J Neurosci 2000, 20:7246-7251
17. Alzuherri H, Chang KC: Calcineurin activates NF-kappaB in skeletal muscle C2C12 cells. Cell Signal 2003, 15:471-478
18. Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P: Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 2003, 35:367-371
19. Schiaffino S, Serrano A: Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol Sci 2002, 23:569-575
20. 2+- dependent calcineurin signalling pathway. Nature 1999, 400:576-581
21. Mitchell PO, Mills ST, Pavlath GK: Calcineurin differentially regulates maintenance and growth of phenotypically distinct muscles. Am J Physiol 2002, 282:C984-C992
22. Chakkalakal JV, Harrison MA, Carbonetto S, Chin E, Michel RN, Jasmin BJ: Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum Mol Genet 2004, 13:379-388
23. Weller B, Massa R, Karpati G, Carpenter S: Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles. Muscle Nerve 1991, 14:771-774
24. Stupka N, Gregorevic P, Plant DR, Lynch GS: The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice. Acta Neuropathol (Berl) 2004, 107:299-310
25. Sangalli L, Bortolotti A, Jiritano L, Bonati M: Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans. Drug Metab Dispos 1988, 16:749-753
26. Siring MS, Fournier M, Ross DJ, Lewis MI: Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol 1998, 84:1967-1975
27. Mehl ML, Kyles AE, Craigmill AL, Epstein S, Gregory CR: Disposition of cyclosporine after intravenous and multi-dose oral administration in cats. J Vet Pharmacol Ther 2003, 26:349-354
28. Granchelli JA, Pollina C, Hudecki MS: Pre-clinical screening of drugs using the mdx mouse. Neuromuscul Disord 2000, 10:235-239
29. Fraysse B, Liantonio A, Cetrone M, Burdi R, Pierno S, Frigeri A, Pisoni M, Camerino C, De Luca A: The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo. Neurobiol Dis 2004, 17:144-154
30. Hartel JV, Granchelli JA, Hudecki MS, Pollina CM, Gosselin LE: Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice. Muscle Nerve 2001, 24:428-432
31. De Luca A, Pierno S, Conte Camerino D: Electrical properties of diaphragm and EDL muscles during the life of dystrophic mice. Am J Physiol 1997, 272:C333-C340
32. Bryant SH, Conte-Camerino D: Chloride channel regulation in the skeletal muscle of normal and myotonic goats. Pfluegers Arch 1991, 417:605-610
33. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Simonetti S, Papadia F, Conte Camerino D: Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine. Br J Pharmacol 2001, 132:1047-1054
34. Fraysse B, Desaphy JF, Pierno S, De Luca A, Liantonio A, Mitolo CI, Conte Camerino D: Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle. FASEB J 2003, 17:1916-1918
35. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450
36. Parekh AB, Penner R: Store depletion and calcium influx. Physiol Rev 1997, 77:901-930
37. Waiser J, Dell K, Bohler T, Dogu E, Gaedeke J, Budde K, Neumayer HH: Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Nephrol Dial Transplant 2002, 17:1568-1577
38. Sun BK, Li C, Lim SW, Jung JY, Lee SH, Kim IS, Kim YS, Kim J, Bang BK, Yang CW: Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney. J Lab Clin Med 2004, 143:175-183
39. Gramolini AO, Belanger G, Thompson JM, Chakkalakal JV, Jasmin BJ: Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events. Am J Physiol 2001, 281:C1300-C1309
40. Pons F, Augier N, Leger JO, Robert A, Tome FM, Fardeau M, Voit T, Nicholson LV, Mornet D, Leger JJ: A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence. FEBS Lett 1991, 282:161-165
41. Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, Morris GE: Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 1991, 115:1695-1700
42. Kumar A, Boriek AM: Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 2003, 17:386-396
43. Gosselin LE, McCormick KM: Targeting the immune system to improve ventilatory function in muscular dystrophy. Med Sci Sports Exer 2004, 36:44-51
44. Grounds MD, Torrisi J: Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 2004, 18:676-682
45. Passerini L, Bernasconi P, Baggi F, Confalonieri P, Cozzi F, Cornelio F, Mantegazza R: Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy. Neuromuscul Disord 2002, 9:828-835
46. Pierno S, Desaphy JF, Liantonio A, De Bellis M, Bianco G, De Luca A, Frigeri A, Nicchia GP, Svelto M, Leoty C, George Jr AL, Conte Camerino D: Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain 2002, 125:1510-1521
47. Petrof BJ, Stedman HH, Shrager JB, Eby J, Sweeney HL, Kelly AM: Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. Am J Physiol 1993, 265:C834-C841
48. Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS: Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am J Pathol 2002, 161:2263-2272
49. Nakamura A, Yoshida K, Takeda S, Dohi N, Ikeda S: Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice. FEBS Lett 2002, 520:18-24
50. Kumar A, Khandelwal N, Malya R, Reid MB, Boriek AM: Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 2004, 18:102-113
51. Yanagita T, Kobayashi H, Uezono Y, Yokoo H, Sugano T, Saitoh T, Minami S, Shiraishi S, Wada A: Destabilization of Na(v)1.7 sodium channel alpha-subunit mRNA by constitutive phosphorylation of extracellular signal-regulated kinase: negative regulation of steady-state level of cell surface functional sodium channels in adrenal chromaffin cells. Mol Pharmacol 2003, 63:1125-1136
52. 2+-release channels: regulation or association? Biochem Biophys Res Commun 2003, 311:1181-1193
53. Porter JD, Merriam AP, Leahy P, Gong B, Feuerman J, Cheng G, Khanna S: Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet 2004, 13:257-269